TW
Theodore T Wang
10% Owner

Theodore T Wang insider trades: Bellerophon Therapeutics (BLPH) stock buys and sales

10% Owner, Bellerophon Therapeutics Last trade Oct 13, 2023 43 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2018
6
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Theodore reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 13, 2023BLPH↓ Sell$112K
Jun 7, 2023BLPH↓ Sell$112K
May 18, 2023BLPH↓ Sell$5.3M
Jun 8, 2020BLPH↑ Buy$97K
Dec 9, 2019TCON↓ Sell$1.1M
Nov 25, 2019BLPH↑ Buy$3K
Jun 12, 2019BLPH↑ Buy$32K
May 22, 2019BLPH↑ Buy$17K
May 21, 2019BLPH↑ Buy$26K
Jan 25, 2019BLPH↑ Buy$315K
Nov 29, 2018TCON↓ Sell$5K
Nov 29, 2018TCON↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Theodore T Wang's insider trades

Theodore T Wang is a 10% owner of Bellerophon Therapeutics (BLPH). Since Nov 29, 2018, Theodore has reported 7 open-market purchases worth $495K and 5 sales worth $6.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (25 filings), other transactions (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.